Cochlear receives FDA approval to lower age of pediatric cochlear implantation
On March 18, Cochlear received FDA approval to lower the age of pediatric cochlear implantation to 9 months. This important change is backed by research and clinical practice that has demonstrated that the earlier a child receives access to sound, the sooner they can develop speech and language. This important change will improve access to the life changing benefits of cochlear implants.
The mission of the American Cochlear Implant (ACI) Alliance is to advance access to the gift of hearing provided by cochlear implantation through research, advocacy and awareness.
Email to a Friend